ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
YS Biopharma Co., Ltd. (YS) stock surged +9.68%, trading at $1.02 on NASDAQ, up from the previous close of $0.93. The stock opened at $0.90, fluctuating between $0.90 and $1.10 in the recent session.
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
Employees | 773 |
Beta | 0.54 |
Sales or Revenue | $687.20M |
5Y Sales Change% | -0.007% |
Fiscal Year Ends | March |
Sector | Healthcare |
Industry | Biotechnology |